Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. NEJM 2009; 10: 961-972.Go to original source...Go to PubMed...
Wood S. SYNTAX year two: Significantly higher MI rate in PCI arm, no increase in CABG strokes after 12 months. www.theheart.org/article/998863/print.do.
Kappetein AP. Two-year outcomes for SYNTAX. European Society of Cardiology 2009 Congress; September 2, 2009: Barcelona, Spain.
Halbersama WB, Arrigoni SC, Mecozzi G, et al. Four-year outcome of OPCAB no-touch with total arterial Y-graft: making the best treatment a daily practice. Ann Thorac Surg 2009; 88: 796-801.Go to original source...Go to PubMed...
Garg S, Serruys PW. Medications on secondary revascularization in the aftermath of the SYNTAX trial. EuroIntervention 2009; 5(Suppl D): D14-D20.Go to PubMed...
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited